Micheal Lee Hebert Ph.D.

Dr. Micheal Hebert counsels clients on strategies for maximizing intellectual property protection and leveraging that protection in several areas of life sciences. His practice includes drafting and prosecuting patent applications in genetics, gene therapy, personalized medicine, pharmaceuticals, virology, antibodies, stem cells, and microbiology. Micheal also has experience conducting due diligence research and analysis for freedom-to-operate investigations, patent validity opinions, patentability opinions, and technology licensing.

Micheal's practice also includes an emphasis on licensing and other commercial transactions in the life sciences. He assists clients in matters related to transfer of intellectual property rights and collaborations between parties, including drafting and negotiating license agreements and joint development agreements. He also performs due diligence assessments of transactions involving the acquisition and transfer of intellectual property rights.

Concentrations

•Life sciences and health care
•Patent portfolio management and strategic counseling
•IP due diligence
•Biotechnology

Recognition & Leadership

Awards & Accolades

•Listed, The Legal 500 United States, Healthcare Life Sciences, 2025
•Listed, The Best Lawyers in America, 'Ones to Watch,' 2021-2026
•Intellectual Property Law, 2025-2026
•Patent Law, 2025-2026
•Health Care Law, 2021-2024 and 2026
•Recipient, NIH, National Service Award, 2005
•Recipient, National Hemophilia Foundation Fellowship, 2006